Home › Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets
 

Keywords :   


Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets

2014-03-02 18:23:35| Biotech - Topix.net

BMO Capital Markets' price objective would indicate a potential downside of 7.80% from the company's current price.

Tags: price capital target industries

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Public Advisory Number 14A
07.11Atlantic Tropical Weather Outlook
07.11Eastern North Pacific Tropical Weather Outlook
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Wind Speed Probabilities Number 14
07.11Hurricane Rafael Forecast Discussion Number 14
07.11Hurricane Rafael Forecast Advisory Number 14
More »